The total synthesis of (+/-)-11-O-debenzoyltashironin.

The total synthesis of (+/-)-11-O-debenzoyltashironin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The total synthesis of (+/-)-11-O-debenzoyltashironin. Abstract Text:

Silas P Cook,Alessandra Polara,Samuel J Danishefsky,Silas P Cook,Alessandra Polara,Samuel J Danishefsky,

The total synthesis of (+/-)-11-O-debenzoyltashironin. Publishing Authors By Initials

SP Cook,A Polara,SJ Danishefsky,SP Cook,A Polara,SJ Danishefsky,

For similar natural sciences: chemistry: chemistry, organic: isomerism: stereoisomerism research abstracts see: natural sciences: chemistry: chemistry, organic: isomerism: stereoisomerism research

PUBMED ID PMID:

MEDLINE DATE:

The total synthesis of (+/-)-11-O-debenzoyltashironin. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Journal of the American Chemical Society

VOLUME: 128

Page Numbers: 16440-1

Journal Abbreviation: J. Am. Chem. Soc.

ISSN: 0002-7863

DAY: 27

MONTH: Dec

YEAR: 2006

The total synthesis of (+/-)-11-O-debenzoyltashironin. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503056

The total synthesis of (+/-)-11-O-debenzoyltashironin. Keywords Mesh Terms:

KEYWORDS: Stereoisomerism

MESH TERMS: chemistry

Chemical & Substance for Abstract: The total synthesis of (+/-)-11-O-debenzoyltashironin. Information

Substance Name: Bridged Compounds

Registry Number: 0

Grant and Affiliation Information for The total synthesis of (+/-)-11-O-debenzoyltashironin.

AFFILIATION: Department of Chemistry, Columbia University, Havemeyer Hall, 3000 Broadway, New York, NY 10027, USA.

Country: United States

AGENCY: United States NHLBI

GRANT: HL 25848

ACRONYM: HL

MEDLINETA: J Am Chem Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The total synthesis of +/--11-O-debenzoyltashironin Related Publications

• A potentially valuable advance in the synthesis of carbohydrate-based anticancer vaccines through extended cycloaddition chemistry.
• A total synthesis of xestodecalactone a and proof of its absolute stereochemistry: interesting observations on dienophilic control with 1,3-disubstituted nonequivalent allenes.
• An interesting issue of Diels-Alder selectivity discovered en route to 11-O-debenzoyltashironin.
• Applications of total synthesis to problems in neurodegeneration: Fascinating chemistry along the way.
• Building complex glycopeptides: Development of a cysteine-free native chemical ligation protocol.
• Chemical synthesis of normal and transformed PSA glycopeptides.
• Complex target-oriented total synthesis in the drug discovery process: the discovery of a highly promising family of second generation epothilones.
• Conformational locking through allylic strain as a device for stereocontrol--total synthesis of grandisine A.
• Creating quaternary centers with high exo stereoselectivity using activated alpha-alkynyl dienophiles.
• Development of efficient methods for accomplishing cysteine-free peptide and glycopeptide coupling.
• Differentiation of nonconventional "carbanions"-the total synthesis of nemorosone and clusianone.
• Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin.
• Free-radical-based, specific desulfurization of cysteine: a powerful advance in the synthesis of polypeptides and glycopolypeptides.
• Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody.
• On the rearrangement of an azaspiroindolenine to a precursor to phalarine: mechanistic insights.
• Studies related to the relative thermodynamic stability of C-terminal peptidyl esters of O-hydroxy thiophenol: emergence of a doable strategy for non-cysteine ligation applicable to the chemical synthesis of glycopeptides.
• The total synthesis of (+)-migrastatin.
• The total synthesis of (+/-)-11-O-debenzoyltashironin.
• The total synthesis of spirotenuipesines A and B.
• Total synthesis of (+)-isomigrastatin.
• Total synthesis of (+)-suaveolindole: establishment of its absolute configuration.
• Total synthesis of (+/-)-jiadifenin, a non-peptidyl neurotrophic modulator.
• Total synthesis of (-)-scabronine G, an inducer of neurotrophic factor production.
• Total synthesis of cribrostatin IV: fine-tuning the character of an amide bond by remote control.
• Total synthesis of paecilomycine A.
• Total synthesis of peribysin E necessitates revision of the assignment of its absolute configuration.
• Total synthesis of phalarine.
• Total synthesis of salinosporamide A.
• Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency.
• Toward fully synthetic glycoproteins by ultimately convergent routes: a solution to a long-standing problem.